Long-term efficacy of plasma-derived hepatitis B vaccine: A 15-year follow-up study among Chinese children

Vaccine

Volumn 17, Issue 20-21, 1999, Pages 2661-2666

  Liao, Su su ^a,b   Li, Rong cheng ^b   Li, Hui ^a,b   Yang, Jin ye ^b   Zeng, Xian jia ^a,b   Gong, Jian ^b   Wang, Shu sheng ^b   Li, Yan ping ^b   Zhang, Kong lai ^a  

^a INSTITUTE OF BASIC MEDICAL SCIENCES   (China)

^b Guangxi Hlth/Anti Epidemic Center   (China)

Author keywords

Chronic HBsAg carriage status; HBsAg; Long term protection; Plasma derived hepatitis B vaccine

Indexed keywords

HEPATITIS B SURFACE ANTIBODY; HEPATITIS B VACCINE;

ANTIBODY TITER; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; HEPATITIS B; HUMAN; IMMUNOGENICITY; IMMUNOLOGICAL MEMORY; INFANT; INTRAMUSCULAR DRUG ADMINISTRATION; MAJOR CLINICAL STUDY; PRESCHOOL CHILD; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; VACCINATION;

DOUBLE-BLIND METHOD; FOLLOW-UP STUDIES; HEPATITIS B ANTIBODIES; HEPATITIS B SURFACE ANTIGENS; HEPATITIS B VACCINES; HUMANS; INFANT; TIME FACTORS; VACCINATION;

EID: 0033522937     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0264-410X(99)00031-6     Document Type: Article

References (10)

1. Hadler S.C., Francis D.P., Maynard J.E., Thompson S.E., Judson F.N., Echenberg D.F., Ostrow D.G., O'Malley P.M., Penley K.A., Altman N.L., Braff E., Shipman G.F., Coleman P.J. Long-term immunogenicity and efficacy of hepatitis B vaccine in homosexual men. N. Engl. J. Med. 315:1986;209-214.
2. Coursaget P., Yvonnet B., Chotard J., Sarr M., Vincelot P., N'doy R., Diop-Mar I., Chiron J.P. Seven-year study of hepatitis B vaccine efficacy in infants from an endemic area (Senegal). Lancet. II:1986;1143-1144.
3. Wainwright R.B., McMahon B.J., Bulkow L.R., Parkinson A.J., Harpster A.P. Protection provided by hepatitis B vaccine in a Yupik Eskimo population - seven-year results. Arch. Intern. Med. 151:1991;1634-1636.
4. Xu H.W., Li D.S., Xu J.W., Wang X.L., Men B.Y., Zheng Q.Q., Liu P.B., Song Q.J., Gao H.Y., Zhuang G.H., Wang W.J., Tang X.H., Wang K., Tao M. Evaluation of long-term efficacy on plasma-derived hepatitis B vaccine. Chin. J. Epidemiol. 13:(6):1992;362-365.
5. Ding L., Zhang M., Wang Y., Zhou S., Kong W., Smego R.A. A 9-year follow-up study of the immunogenicity and long-term efficacy of plasma-derived hepatitis B vaccine in high-risk neonates. Clin. Infect. Dis. 17:1993;475-479.
6. Coursaget P., Leboulleux D., Soumare M., Cann P.L., Yvonnet B., Chiron J.P., Coll-Seck A.M., Diop-Mar I. Twelve-year follow-up study of hepatitis B immunization of Senegalese infants. J. Hepatol. 21:1994;250-254.
7. Xu Z.Y., Cao H.L., Liu C.B., Yang J.Y., Yan T.Q., Sun Y.D., Sha Q.H., Zhao S.J. A cross-sectional study of long-term effectiveness of universal infant hepatitis B vaccination program. Chin. J. Exp. Clin. Virology. 9:(suppl):1995;13-16.
8. Xu H.W., Sui X.F., Men B.Y., Wang X.L., Xu J.W., Zheng Q.Q., Zhuang G.H., Liu P.B., Zhang J.Y., Li D.S. Evaluation of efficacy of plasma-derived hepatitis B vaccine at six years after vaccination. J. Xi'An Med. Univ. 16:1995;368-371.
9. Katkov W.N., Dienstag J.L. Prevention and therapy of viral hepatitis. Semi Liver Dis. 11:1991;165-174.
10. Hadler S.C. Are booster doses of hepatitis B vaccine necessary? Ann. Intern. Med. 108:1988;457-458.